High-throughput synthesis of conopeptides: A safety-catch linker approach enabling disulfide formation in 96-well format

Journal of Peptide Science

Volumn 13, Issue 2, 2007, Pages 133-141

  Brust, Andreas ^a   Tickle, Alice E ^a  

^a Xenome Ltd   (Australia)

Author keywords

Conopeptides; Disulfide bonds; High throughput synthesis; Safety catch linker; Solid phase peptide synthesis

Indexed keywords

AMMONIA; CARBONYL DERIVATIVE; CYSTEINE; DIMETHYL SULFOXIDE; DISULFIDE; IODIDE; PEPTIDE DERIVATIVE; TRIFLUOROACETIC ACID;

ARTICLE; DISULFIDE BOND; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; METHODOLOGY; OXIDATION; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN SECRETION; SOLID PHASE SYNTHESIS;

ACRYLIC RESINS; AMINO ACID SEQUENCE; ANALGESICS; ANIMALS; CONOTOXINS; CYSTINE; DISULFIDES; HUMANS; MOLECULAR SEQUENCE DATA; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 33847159894     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.825     Document Type: Article

References (34)

1. Newman DJ, Cragg GM. Marine natural products and related compounds in clinical and advanced preclinical trials. J. Nat. Prod. 2004; 67: 1216-1238.
2. Armishaw CJ, Alewood PF. Conotoxins as research tools and drug leads. Curr. Protein Pept. Sci. 2005; 6: 221-240.
3. Livett BG, Gayler KR, Khalil Z. Drugs from the sea: conopeptides as potential therapeutics. Curr. Med. Chem. 2004; 11: 1715-1723.
4. Alonso D, Khalil Z, Satkunanthan N, Livett BG. Drugs from the sea: conotoxins as drug leads for neuropathic pain and other neurological conditions. Mini-Rev. Med. Chem. 2003; 3: 785-787.
5. Shen GS, Layer RT, McCabe RT. Conopeptides: from deadly venoms to novel therapeutics. Drug Discov. Today 2000; 3: 98-106.
6. Nielsen CK, Lewis RJ, Alewood D, Drinkwater R, Palant E, Patteson M, Yaksh TL, McCumber D, Smith MT. Anti-allodynic efficacy of the chi-conopeptide, Xen2174, in rats with neuropathic pain. Pain 2005; 118:112-124.
7. Lima V, Mueller A, Kamikihara SY, Raymundi V, Alewood D, Lewis RJ, Chen X, Minneman KP, Pupo AS. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alphal-adrenoceptor subtypes in rat vas deferens, spleen and aorta. Eur. J. Pharmacol. 2005; 508: 183-192.
8. Obata H, Conklin D, Eisenach JC. Spinal noradrenaline transporter inhibition by reboxetine and Xen2174 reduces tactile hypersensitivity after surgery in rats. Pain 2005; 113:271-276.
9. Chen Z, Rogge G, Hague C, Alewood D, Colless B, Lewis R, Minneman K. Subtype-selective allosteric or competitive inhibition of human alpha-1-adrenergic receptors by rho-T1A. J. Biol. Chem. 2004; 279: 35326.
10. Lewis RJ, Garcia ML. Therapeutic potential of venom peptides. Nat. Rev. Drug Discov. 2003; 2: 790-802.
11. Sharpe IA, Palant E, Schroeder CI, Kaye DM, Adams DJ, Alewood PF, Lewis RJ. Inhibition of the norepinephrine transporter by the venom peptide chi-MrIA. Site of action, Na+ dependence, and structure-activity relationship. J. Biol. Chem. 2003; 278: 40317-40323.
12. Sharpe IA, Thomas L, Loughnan M, Motin L, Palant E, Croker DE, Alewood D, Chen S, Graham RM, Alewood PF, Adams DJ, Lewis RJ. Allosteric alpha 1-adrenoreceptor antagonism by the conopeptide rho-T1A. J. Biol. Chem. 2003; 278: 34451-34457.
13. Sharpe IA, Gehrmann J, Loughnan ML, Thomas L, Adams DA, Atkins A, Palant E, Craik DJ, Adams DJ, Alewood PF, Lewis RJ. Two new classes of conopeptides inhibit the alpha 1-adrenoceptor and noradrenaline transporter. Nat. Neurosci. 2001; 4: 902-907.
14. Drinkwater R. For updates on the development of Xen2174 visit http://www.xenome.com [2006].
15. Soell R, Beck-Sickinger AG. On the synthesis of Orexin a: a novel one-step procedure to obtain peptides with two intramolecular disulphide bonds. J. Pept. Sci. 2000; 6: 387-397.
16. Hargittai B, Barany G. Controlled syntheses of natural and disulfide mispaired regioisomers of α-conotoxin SI. J. Pept. Res. 1999; 54: 468-479.
17. Camarero JA, Giralt E, Andreu D. Cyclization of a large disulfide peptide in the solid phase. Tetrahedron Lett. 1995; 36:1137-1140.
18. Munson MC, Barany G. Synthesis of α-conotoxin SI, a bicyclic tridecapeptide amide with two disulfide bridges: Illustration of novel protection schemes and oxidation strategies. J. Am. Chem. Soc. 1993; 115: 10203-10210.
19. Patek M, Lebl M. Safety-catch anchoring linkage for synthesis of peptide amides by Boc/Fmoc strategy. Tetrahedron Lett. 1991; 32: 3891.
20. Patek M. Multistep deprotection for peptide chemistry. Int. J. Pept. Protein Res. 1993; 42: 97-117.
21. Katajisto J, Karskela T, Heinonen P, Loennberg H. An orthogonally protected α, α-bis(aminomethyl)-β-alanine building block for the construction of glycoconjugates on a solid support. J. Org. Chem. 2002; 67: 7995-8001.
22. Besser D, Muener B, Kleinwaechter P, Greiner G, Seyfarth L, Steinmetzer T, Arad O, Reissmann S. Synthesis and characterization of octapeptide somatostatin analogues with backbone cyclization: comparison of different strategies, biological activities and enzymatic stabilities. J. Prakt. Chem. 2000; 342: 537-545.
23. Brik A, Keinan E, Dawson PE. Protein synthesis by solid-phase chemical ligation using a safety catch linker. J. Org. Chem. 2000; 65: 3829-3835.
24. Olivera BM, Cruz LJ. Conotoxins in retrospect. Toxicon 2001; 39: 7-14.
25. Cartier GE, Yoshikami D, Gray WR, Luo S, Olivera BM, McIntosh JM. A new α-conotoxin which targets α3β2 nicotinic acetyl choline receptors. J. Biol. Chem. 1996; 271: 7522-7528.
26. Gray WR, Luque A, Olivera BM, Barret J, Cruz LJ. Peptide toxins from Conus geographus venom. J. Biol. Chem. 1981; 256: 4734-4740.
27. Zafarena GC, Ramilo C, Gray WR, Karlstrom R, Olivera BM, Cruz LJ. Phylogenetic specificity of cholinergic ligands: α-Conotoxin SI. Biochemistry 1988; 27: 7102-7105.
28. McIntosh JM, Yoshikami D, Mahe E, Nielsen DB, Rivier JE, Gray WR, Olivera BM. A nicotinic acetylcholine receptor ligand of unique specificity, α-Conotoxin ImI. J. Biol. Chem. 1994; 269: 16733-16739.
29. Balaji RA, Ohtake A, Sato K, Gopalakrihnkone P, Kini RM, Seow KT, Bay BH. λ-Conotoxins, a new family of conotoxins with unique disulfide pattern and protein folding. Isolation and characterization from the venom of conus marmoreus. J. Biol. Chem. 2000; 9-75: 39516-39522.
30. McIntosh JM, Corpuz GP, Layer RT, Garret JE, Wagstaff JD, Bulaj G, Vyazovkina A, Yoshikami D, Cruz LJ, Olivera BM. Isolation and characterization of a novel conus peptide with apparent antinociceptive activity. J. Biol. Chem. 2000; 275: 32391-32397.
31. Sarin VK, Kent SBH, Tam JP, Merrifield RB. Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction. Anal. Biochem. 1981; 117:147-157.
32. 4I/TFA: Compatibility with peptides containing cysteine and aromatic amino acids. Tetrahedron 1998; 54: 15273-15286.
33. Otaka A, Koide T, Shide A, Fujii N. Application of Dimethylsulphoxide (DMSO)/Trifluoracetic acid (TFA) oxidation to the synthesis of Cystine-containing peptides. Tetrahedron Lett. 1991; 132: 1223.
34. Otaka A, Koide T, Fujii N. Investigation of the Dimethylsulfoxide-Trifluoracetic acid oxidation system for the synthesis of cystine-containing peptides. Chem. Pharm. Bull. 1993; 41: 1030-1034.